1. Home
  2. Labeler Index
  3. Teva Neuroscience, Inc.
  4. 68546-172
  5. NDC Package Code: 68546-172-66 Austedo

NDC Package 68546-172-66 Austedo

Deutetrabenazine Tablet, Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68546-172-66
Package Description:
60 TABLET, COATED in 1 BOTTLE
Product Code:
68546-172
Proprietary Name:
Austedo
Non-Proprietary Name:
Deutetrabenazine
Substance Name:
Deutetrabenazine
Usage Information:
Deutetrabenazine is used to decrease involuntary movements (chorea) caused by Huntington's disease. It is also used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). However, it is not a cure for the Huntington's disease or tardive dyskinesia. Reducing involuntary movements will help you take part in more of your normal daily activities. This medication is thought to work by decreasing the amount of certain natural substances in the brain that affect how your nerves and muscles work (monoamines such as dopamine, serotonin, and norepinephrine).
11-Digit NDC Billing Format:
68546017266
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Teva Neuroscience, Inc.
Dosage Form:
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
DEUTETRABENAZINE 12 mg/1
Sample Package:
Yes
FDA Application Number:
NDA208082
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
04-12-2017
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
68546-172-6060 TABLET, COATED in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 68546-172-66?

The NDC Packaged Code 68546-172-66 is assigned to a package of 60 tablet, coated in 1 bottle of Austedo, a human prescription drug labeled by Teva Neuroscience, Inc.. The product's dosage form is tablet, coated and is administered via oral form.

Is NDC 68546-172 included in the NDC Directory?

Yes, Austedo with product code 68546-172 is active and included in the NDC Directory. The product was first marketed by Teva Neuroscience, Inc. on April 12, 2017 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 68546-172-66?

The 11-digit format is 68546017266. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-268546-172-665-4-268546-0172-66